Crinetics Pharmaceuticals Inc. (CRNX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Crinetics Pharmaceuticals...

    NASDAQ: CRNX · Real-Time Price · USD
    41.02
    -0.49 (-1.18%)
    At close: Oct 03, 2025, 3:23 PM

    Crinetics Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 264.55M 54.9M 32.67M 200.69M
    Short-Term Investments
    		 1.09B 503.66M 301.75M 133.01M
    Long-Term Investments
    		 800K 1.77M 1.97M 1.01M
    Other Long-Term Assets
    		 2.83M 2M 37K 568K
    Receivables
    		 8.47M 9.35M 2.42M 2.03M
    Inventory
    		 n/a n/a n/a -2.03M
    Other Current Assets
    		 1.71M 1.58M 4.83M 2.03M
    Total Current Assets
    		 1.38B 574.15M 345.18M 344.72M
    Property-Plant & Equipment
    		 55.58M 57.43M 4.99M 4.72M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 59.2M 61.2M 6.99M 6.29M
    Total Assets
    		 1.43B 635.35M 352.18M 351.01M
    Account Payables
    		 5.85M 6.55M 6.88M 3.42M
    Deferred Revenue
    		 2.18M 2.06M 2.24M -939K
    Short-Term Debt
    		 7.15M 4.17M 1.05M 939K
    Other Current Liabilities
    		 -7.14M 12.47M 7.42M n/a
    Total Current Liabilities
    		 59.68M 43.94M 27.72M 15.99M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 829K n/a 6.1M 2K
    Total Long-Term Liabilities
    		 50.1M 52.3M 8.13M 3.08M
    Total Liabilities
    		 109.79M 96.25M 35.85M 19.07M
    Total Debt
    		 51.72M 51.73M 3.08M 3.07M
    Book Value
    		 1.32B 539.11M 316.33M 331.94M
    Book Value Per Share
    		 16.40 9.28 6.09 8.64
    Common Stock
    		 2.28B 1.19B 759.43M 607.58M
    Retained Earnings
    		 -952.11M -653.7M -439.17M -275.25M
    Comprehensive Income
    		 963K 977K -3.93M -382K
    Shareholders Equity
    		 1.32B 539.11M 316.33M 331.94M
    Total Investments
    		 1.09B 505.43M 301.75M 134.02M

    Add to Watchlist